Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines
NCT00138255 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2010-08-27
Summary
The purpose of this study is to see if the MMR and chickenpox vaccines work as well in premature infants as in children that were carried to full term. A group of children who were carried full-term will be matched for age, sex, and race and will be used for comparison.
Conditions
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Eligibility
- Max Age
- 16 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-06-30
- Completion
- 2005-06-30
Countries
- United States
Study Locations
More Related Trials
-
Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children
NCT00197015 ·Status: COMPLETED ·Phase: PHASE3
-
Ontogeny of Measles Immunity in Infants
NCT00240916 ·Status: COMPLETED
-
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age
NCT02184572 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
NCT01681992 ·Status: COMPLETED ·Phase: PHASE3
-
Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age
NCT01702428 ·Status: COMPLETED ·Phase: PHASE3
-
To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)
NCT00363545 ·Status: COMPLETED ·Phase: PHASE3
-
Making Decisions About the Measles-Mumps-Rubella Vaccine
NCT01369394 ·Status: COMPLETED ·Phase: NA
-
Safety Study of a Refrigerator-stable Formulation of VARIVAX®
NCT00432731 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants
NCT01098474 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy
NCT06369272 ·Status: COMPLETED
-
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients
NCT07195032 ·Status: RECRUITING ·Phase: PHASE4
-
Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age
NCT00197002 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines
NCT01738841 ·Status: WITHDRAWN
-
Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age
NCT06618196 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
NCT00578175 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants
NCT00969228 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants
NCT01763268 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.
NCT00609492 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
NCT00289783 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
NCT04535037 ·Status: COMPLETED ·Phase: PHASE4
-
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
NCT00463437 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine
NCT02153866 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR
NCT04638985 ·Status: UNKNOWN ·Phase: PHASE4
-
Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine
NCT00406211 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants
NCT01204658 ·Status: COMPLETED ·Phase: PHASE2